Omada Health (NASDAQ:OMDA) Cut to Hold at Zacks Research

Zacks Research lowered shares of Omada Health (NASDAQ:OMDA) from a strong-buy rating to a hold rating in a report issued on Wednesday morning,Zacks reports.

Several other analysts have also issued reports on the stock. Needham & Company LLC restated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Friday, September 11th. Canaccord Genuity Group lifted their price target on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research report on Tuesday, July 21st. Citizens Jmp boosted their price target on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research note on Friday, August 14th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Finally, Barclays lowered their price objective on shares of Omada Health from $27.00 to $24.00 and set an “overweight” rating for the company in a research report on Wednesday, October 28th. Eleven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Omada Health Trading Down 20.4%

Omada Health stock traded down $3.86 during mid-day trading on Wednesday, hitting $15.09. The company’s stock had a trading volume of 4,709,304 shares, compared to its average volume of 1,032,454. The firm has a market capitalization of $923.81 million, a PE ratio of 71.86 and a beta of 2.13. Omada Health has a 1 year low of $10.28 and a 1 year high of $25.45. The stock’s fifty day moving average is $20.14 and its two-hundred day moving average is $17.74.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.08. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. The company had revenue of $91.31 million for the quarter. On average, equities analysts expect that Omada Health will post 0.09 EPS for the current fiscal year.

Insider Activity at Omada Health

In other news, CEO Sean P. Duffy sold 21,572 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total value of $509,530.64. Following the completion of the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,728,156.82. This trade represents a 4.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $25.02, for a total transaction of $221,827.32. Following the completion of the transaction, the president owned 307,372 shares of the company’s stock, valued at $7,690,447.44. This trade represents a 2.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 119,014 shares of company stock worth $2,711,405 in the last three months. 6.38% of the stock is owned by company insiders.

Hedge Funds Weigh In On Omada Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. China Universal Asset Management Co. Ltd. acquired a new position in shares of Omada Health in the third quarter worth $70,000. Sterling Capital Management LLC boosted its holdings in Omada Health by 1,161.6% in the third quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock valued at $33,000 after purchasing an additional 1,452 shares during the period. Robeco Institutional Asset Management B.V. purchased a new position in Omada Health in the third quarter valued at $1,100,000. Counterpoint Mutual Funds LLC acquired a new position in Omada Health during the 3rd quarter worth $595,000. Finally, State of Alaska Department of Revenue acquired a new position in Omada Health during the 3rd quarter worth $59,000.

Omada Health News Summary

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
• Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
• Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
• Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

Omada Health Company Profile

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.